Accuracy of the GlucoWatch G2 Biographer and the continuous glucose monitoring system during hypoglycemia: experience of the Diabetes Research in Children Network.

OBJECTIVE The goal of this study was to assess the accuracy of the GlucoWatch G2 Biographer (GW2B) and the continuous glucose monitoring system (CGMS) during hypoglycemia in children and adolescents with type 1 diabetes. RESEARCH DESIGN AND METHODS During a 24-h clinical research center stay, 91 children and adolescents with type 1 diabetes (aged 3.5-17.7 years) wore one or two CGMSs, and 89 of these subjects wore one or two GW2Bs. Frequent serum glucose determinations were made during the day, overnight, and during insulin-induced hypoglycemia resulting in 192 GW2B reference pairs and 401 CGMS reference pairs during hypoglycemia (reference glucose < or =60 mg/dl). RESULTS During hypoglycemia, the median absolute difference between the 192 GW2B reference glucose pairs was 26 mg/dl and between the 401 CGMS reference glucose pairs was 19 mg/dl with 31 and 42%, respectively, of the sensor values within 15 mg/dl of the reference glucose. Sensitivity to detect hypoglycemia when the GW2B alarm level was set to 60 mg/dl was 23% with a false-alarm rate of 51%. Analyses suggested that modified CGMS sensors that became available in November 2002 might be more accurate than the original CGMS sensors (median absolute difference 15 vs. 20 mg/dl). CONCLUSIONS These data show that the GW2B and the CGMS do not reliably detect hypoglycemia. Both of these devices perform better at higher glucose levels, suggesting they may be more useful in reducing HbA1c levels than in detecting hypoglycemia.

[1]  Stuart A Weinzimer,et al.  Analysis of continuous glucose monitoring data from non-diabetic and diabetic children: a tale of two algorithms. , 2003, Diabetes technology & therapeutics.

[2]  A. Moran,et al.  Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled type 1 diabetes. , 2002, Diabetes care.

[3]  R O Potts,et al.  Clinical evaluation of the GlucoWatch biographer: a continual, non-invasive glucose monitor for patients with diabetes. , 2001, Biosensors & bioelectronics.

[4]  Aaron B. Neinstein,et al.  Nocturnal hypoglycemia detected with the Continuous Glucose Monitoring System in pediatric patients with type 1 diabetes. , 2002, The Journal of pediatrics.

[5]  The accuracy of the CGMS in children with type 1 diabetes: results of the diabetes research in children network (DirecNet) accuracy study. , 2003, Diabetes technology & therapeutics.

[6]  Robert Tibshirani,et al.  An Introduction to the Bootstrap , 1994 .

[7]  R. Ehrlich,et al.  Intellectual Deficits Associated With Early Onset of Insulin-Dependent Diabetes Mellitus in Children , 1987, Diabetes Care.

[8]  R O Potts,et al.  Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes. , 1999, Diabetes care.

[9]  R. Potts,et al.  Effect of acetaminophen on the accuracy of glucose measurements obtained with the GlucoWatch biographer. , 2000, Diabetes technology & therapeutics.

[10]  P. Böhme,et al.  Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs. , 2003, Diabetes care.

[11]  R. Ehrlich,et al.  The effect of hypoglycemic seizures on cognitive function in children with diabetes: a 7-year prospective study. , 1999, The Journal of pediatrics.

[12]  D. Dunger,et al.  Hypoglycemia prevalence in prepubertal children with type 1 diabetes on standard insulin regimen: use of continuous glucose monitoring system. , 2003, Diabetes care.

[13]  L. Jovanovic,et al.  Noninvasive glucose monitoring: comprehensive clinical results. Cygnus Research Team. , 1999, JAMA.

[14]  R O Potts,et al.  Detection of hypoglycemia with the GlucoWatch biographer. , 2001, Diabetes care.

[15]  H. Chase,et al.  Cost‐effectiveness of use of the GlucoWatch® Biographer in children and adolescents with type 1 diabetes: a preliminary analysis based on a randomized controlled trial , 2003, Pediatric diabetes.

[16]  Benjamin Glaser,et al.  Reproducibility of glucose measurements using the glucose sensor. , 2002, Diabetes care.

[17]  W. Tamborlane,et al.  Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. , 2001, Diabetes care.

[18]  N. Fineberg,et al.  Fear of Hypoglycemia in the Parents of Children and Adolescents With Diabetes: Maladaptive or Healthy Response? , 1997, The Diabetes educator.